BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study-Reference-Cited by-同舟云学术

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study

Published:2015-07 Issue:7 Volume:17 Page:569-577
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Zhen David B.,Rabe Kari G.,Gallinger Steven,Syngal Sapna,Schwartz Ann G.,Goggins Michael G.,Hruban Ralph H.,Cote Michele L.,McWilliams Robert R.,Roberts Nicholas J.,Cannon-Albright Lisa A.,Li Donghui^ORCID,Moyes Kelsey,Wenstrup Richard J.,Hartman Anne-Renee,Seminara Daniela,Klein Alison P.,Petersen Gloria M.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim2014153.pdf

Reference40 articles.

1. SEER Cancer Statistics, 1975–2011;Howlader,2014

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of mutation-independent BRCA2 protein deficiency expands diagnostics and selection of pancreatic cancer patients for personalized therapy with PARP1 inhibitors;2024-09-08

2. Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Two Japanese families with familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report;Hereditary Cancer in Clinical Practice;2024-07-03

4. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk;Cancer Epidemiology, Biomarkers & Prevention;2024-06-13

5. Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies;American Society of Clinical Oncology Educational Book;2024-06